Nathanael Gray,Sang Min Lim,Hwan Geun Choi,Kenneth Dale Westover,Matthew Meyerson
申请号：
US14775162
公开号：
US10723753B2
申请日:
2014.03.13
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Described herein are compounds of Formulae (I)-(II), and pharmaceutically acceptable salts, and pharmaceutical compositions thereof. Also provided are methods and kits involving the inventive compounds or compositions for treating or preventing proliferative diseases such as cancers (e.g., lung cancer, large bowel cancer, pancreas cancer, biliary tract cancer, or endometrial cancer), benign neoplasms, angiogenesis, inflammatory diseases, autoinflammatory diseases, and autoimmune diseases in a subject.
